NNC 38-1049
From Wikipedia, the free encyclopedia
Names | |
---|---|
IUPAC name
1-(4-chlorophenyl)-4-(4-cyclopentylpiperazine-1-yl)-4-oxobutan-1-one
|
|
Identifiers | |
757183-18-9 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL97170 |
ChemSpider | 7974195 |
PubChem | 9798429 |
|
|
|
|
Properties | |
C19H25ClN2O2 | |
Molar mass | 348.866 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
NNC 38-1049 is a histamine antagonist selective for the H3 subtype. It has anorectic effects in animal studies and is being researched as a potential treatment for obesity.[1][2]
References[edit]
- ^ Malmlöf K, Zaragoza F, Golozoubova V, et al. (December 2005). "Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight". Int J Obes (Lond). 29 (12): 1402–12. doi:10.1038/sj.ijo.0803036. PMID 16151415.
- ^ Malmlöf K, Golozoubova V, Peschke B, Wulff BS, Refsgaard HH, Johansen PB, Cremers T, Rimvall K. Increase of neuronal histamine in obese rats is associated with decreases in body weight and plasma triglycerides. Obesity (Silver Spring). 2006 Dec;14(12):2154-62. PMID 17189541
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
This article about a ketone is a stub. You can help Wikipedia by expanding it. |